Sara A. Hurvitz, MD
Advertisement
Articles by Sara A. Hurvitz, MD
Advertisement
Latest Updated Articles
Advice for Community Physicians on Managing HER2+ Breast CancerPublished: March 7th 2023 | Updated:
Dr. Hurvitz on the Rationale for the coopERA Breast Cancer Trial in ER+/HER2- Breast CancerPublished: September 29th 2021 | Updated:
SABCS 2021 Updates in ER+ Breast CancerPublished: January 31st 2022 | Updated:
Molecular Testing Platforms in Breast CancerPublished: May 11th 2022 | Updated:
Molecular Testing in Relapsed/Refractory HR+ Metastatic Breast CancerPublished: March 2nd 2023 | Updated:
Factors in Selecting 1L Therapy for Patients With HR+ Metastatic Breast CancerPublished: February 23rd 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5